Skip to main content

Table 2 Demographical and clinical features at non-Hodgkin lymphoma diagnosis

From: The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study

Variables Categories n (%)
Total   215
Gender Male 172 (80.0)
Age (years) <35 31 (14.4)
35-49 136 (63.3)
≥50 48 (22.3)
  Mean (SD) 43.2 (9.0)
Period of Diagnosis 1998-2002 71 (33.0)
  2003-2007 88 (40.9)
  2008-2012 56 (26.1)
IDU Yes 96 (42.8)
Migrants Yes 28 (8.7)
Previous AIDS defining event Yes 81 (37.7)
HBV or/and HCV co-infection Yes 111 (51.6)
cART Yes 172 (80.0)
CD4 cell count, cell/mm3 <200 104 (54.2)
≥200 88 (45.8)
  Mean (SD) 275.9 (235.3)
CD4/CD8 Ratio <1 158 (89.3)
≥1 19 (10.7)
  Mean (SD) 0.46 (0.50)
HIV-RNA, copies/mL Undetectable 49 (26.1)
Positive 139 (73.9)
  Mean (SD)* 113208.8 ( 310601.3)
Status at the end of the follow-up Alive 117 (54.4)
Dead 98 (45.6)
  1. Abbreviations: SD Standard Deviation, IDU Intravenous Drug Use, HBV Hepatitis B Virus, HCV Hepatitis C Virus, cART combined Antiretroviral Therapy, *In subjects with positive HIV-RNA.